Applied DNA Stock News

Applied DNA Sciences (NASDAQ:APDN) reported its Q4 earnings results on Thursday, December 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug Reata Pharmaceuticals, Inc.

Applied DNA Sciences (NASDAQ:APDN) is set to give its latest quarterly earnings report on Thursday, 2021-12-09. Here's what investors need to know before the announcement.

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative development. The sector r

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN--Applied DNA to report fourth quarter and full-year 2021 financial results after market close on December 9, 2021.

Cannabis producer Flora Growth Corp. (NASDAQ: FLGC) announced on Monday that it has inked a licensing agreement with Tonino Lamborghini to produce and distribute Tonino Lamborghini branded cannabis be

Cannabis producer Flora Growth Corp. (NASDAQ: FLGC ) announced on Monday that it has inked a licensing agreement with Tonino Lamborghini to produce and distribute Tonino Lamborghini branded cannabis beverages across North America and Colombia under their renowned luxury lifestyle brand. Under the terms of the agreement, the Miami and Toronto-based company revealed that it will retain the right of first refusal to produce and distribute any CBD or CBG products globally under the Tonino Lamborghini brand. The products will be manufactured through Flora''s division, using Applied DNA Sciences, Inc. (NASDAQ: APDN ) molecular tagging and authentication technology to ensure product verification, in line with the new age of cannabis consumer packaged goods. The company will also retain Full story available on Benzinga.com

NEW YORK , Nov. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, CODX, PRPO, XAIR, and CEMI. … Full story available on Benzinga.com

The stock price of Applied DNA Sciences Inc (NASDAQ: APDN) increased by over 50% pre-market today. This is why it happened.

Applied DNA Sciences Inc (NASDAQ:APDN) plans to introduce its Linea 2.0 COVID-19 Assay for the SARS-CoV-2 E and N genes after submitting its validation data to the New York State Department of Heal

Wall Street brokerages expect Applied DNA Sciences, Inc. (NASDAQ:APDN) to post $2.84 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Applied DNA Sciences earnings, with estimates ranging from $2.75 million to $2.93 million. Applied DNA Sciences reported sales of $310,000.00 in the same quarter last year, which []

Equities analysts expect Applied DNA Sciences, Inc. (NASDAQ:APDN) to report ($0.32) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Applied DNA Sciences earnings, with the lowest EPS estimate coming in at ($0.38) and the highest estimate coming in at ($0.25). Applied DNA Sciences reported earnings []

The stock price of Applied DNA Sciences Inc (NASDAQ: APDN) increased by over 20% yesterday. This is why it happened.

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #covid19--Applied DNA adds Sarah Lawrence College as COVID-19 testing customer.

STONY BROOK, N.Y.--(BUSINESS WIRE)---- $APDN #supplychainsecurity--Applied DNA Receives Purchase Orders Totaling $1.6M to Tag Textile Fibers; Progressing Textile Projects Representing New Commercial O